The molecular understanding of how signal transduction pathways govern immune cell function depends upon elucidating the physical interactions between pathway components and defining how these interactions transmit signals and provide regulation. Several approaches toward discovering relevant protein-protein interactions in signaling pathways have become standard tools in the last few decades, including yeast-two-hybrid screening with a bait protein of interest, affinity purification of a bat followed by mass spectrometry of associated proteins, the probing of protein chips with a recombinant bait protein, and others. Each technique has yielded important findings in a variety of fields and each has its particular advantages and disadvantages depending on the application. To enable our studies of antigen receptor signaling and how its dysregulation contributes to immunodeficiency, autoimmunity and lymphoma, we have sought novel screening approaches for identifying protein-protein interactions. Specifically, we desired a technique that would allow us to screen for protein-protein interactions a) in live mammalian cells, b) with a quantitative measure of the interaction, c) in a cost-efficient and d) high-throughput manner, that e) would be highly modular and therefore easily adaptable for many applications. In this application we propose exploratory and developmental studies to establish such a screening approach based upon Bioluminescence Resonance Energy Transfer (BRET), which occurs between a Renilla luciferase derivative, Rluc8, and YPet, a YFP variant, provided the distance between the proteins is equal to or less than ~100 . Our pilot studies suggest that a library of YPet-cDNA fusions can be screened easily in a high-throughput manner in live mammalian cells for proteins that associate and permit BRET with an individual Bait-Rluc8 fusion protein. We propose to demonstrate the advantages of this technique, develop it into a standardized approach, and generate reagents for screening that will be of general use to the field and freely distributed.

Public Health Relevance

A mechanistic understanding of the molecular circuitry that governs immune cell behavior and how its dysegulation causes disease depends upon a detailed knowledge of the protein-protein interactions that execute and regulate cellular functions. This proposal is designed to develop and demonstrate the utility of novel methodology and reagents for uncovering protein-protein interactions. Our studies are likely to offer new approaches and targets for the development of therapies designed to ameliorate immunodeficiency, autoimmunity, lymphoma and other immune-related human diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI118606-02
Application #
9059019
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Gondre-Lewis, Timothy A
Project Start
2015-05-01
Project End
2017-04-30
Budget Start
2016-05-01
Budget End
2017-04-30
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21205
Pedersen, Sarah M; Chan, Waipan; Jattani, Rakhi P et al. (2015) Negative Regulation of CARD11 Signaling and Lymphoma Cell Survival by the E3 Ubiquitin Ligase RNF181. Mol Cell Biol 36:794-808